Lifestyle Interventions to Tackle Cardiovascular Risk in Thyroid Hormone Signaling Disorders
Nutrients · 20.06.2025 · 17 (13) · 2053
DOI: 10.3390/nu17132053 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 20.06.2025. Verfasst von Simone Rodolfi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology and Translational Medicine, University of Milan, 20100 Milan, Italy. Hauptthemen laut MEDLINE: Thyroid Hormones, Cardiovascular Diseases, Life Style, Thyroid Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, Rome, Italian Ministry of Health.
Abstract (Originalsprache)
Thyroid hormones (THs) play a central role in cardiovascular and metabolic regulation, influencing lipid metabolism, insulin sensitivity and resting energy expenditure. Inherited disorders of impaired sensitivity to THs—including resistance to thyroid hormone alpha (RTHα) and beta (RTHβ), monocarboxylate transporter 8 (MCT8) deficiency and selenoprotein deficiency—lead to complex, multisystemic clinical features. Although these conditions are rare, with RTHβ being the most common and affecting about 1 in 20,000 newborns, they share clinical features with more prevalent thyroid disorders, such as hypothyroidism and hyperthyroidism, as well as neurological manifestations including muscle wasting and spasticity. These conditions present abnormal patterns of thyroid function and are associated with tissue-specific comorbidities such as arrhythmias, heart failure, dyslipidemia, hepatic steatosis, insulin resistance, and metabolic syndrome. To date, no targeted or controlled studies have evaluated the impact of lifestyle modifications in these patient populations. Therefore, this narrative review proposes plausible management strategies based on pathophysiological insights into the effects of thyroid hormones on target organs, combined with clinical reasoning and evidence extrapolated from related disorders. Physical exercise and diet may complement pharmacological treatments (e.g., levothyroxine or TRIAC) to improve cardiovascular and metabolic outcomes. In RTHβ, aerobic exercise enhances cardiovascular health, while a Mediterranean diet supports lipid control and glycemic parameters. In RTHα, physical exercise may aid neuromotor development, and a fluid-rich, fiber-moderated diet can alleviate constipation. In MCT8 deficiency, physiotherapy may improve mobility and relieve contractures, while nutritional support (e.g., feeding tube, gastrostomy) can be necessary to tackle feeding difficulties and reduce pulmonary complications. In selenoprotein deficiency, low-to-moderate physical exercise and an antioxidant-rich diet may protect against oxidative stress at several tissue levels. Although quantitative evidence is limited, this narrative review synthesizes current insights, providing a meaningful basis for future validation and research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biotechnology and Translational Medicine, University of Milan, 20100 Milan, Italy.
- IRCCS Istituto Auxologico Italiano, Department of Endocrine and Metabolic Diseases, 20100 Milan, Italy.
ORCID-Profile: Simone Rodolfi, Luca Persani
Förderung
- Italian Ministry of Health, Rome
- Italian Ministry of Health
Zitieren
APA
Rodolfi, S., Rurale, G., Marelli, F., Persani, L., & Campi, I. (2025). Lifestyle Interventions to Tackle Cardiovascular Risk in Thyroid Hormone Signaling Disorders. Nutrients, 17(13), 2053. https://doi.org/10.3390/nu17132053
Vancouver
Rodolfi S, Rurale G, Marelli F, Persani L, Campi I. Lifestyle Interventions to Tackle Cardiovascular Risk in Thyroid Hormone Signaling Disorders. Nutrients. 2025;17(13):2053. doi:10.3390/nu17132053
BibTeX
@article{Rodolfi2025,
author = {Rodolfi, Simone and Rurale, Giuditta and Marelli, Federica and Persani, Luca and Campi, Irene},
title = {Lifestyle Interventions to Tackle Cardiovascular Risk in Thyroid Hormone Signaling Disorders},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {13},
pages = {2053},
doi = {10.3390/nu17132053}
}
EUVIMED